Colorado’s Psychedelics Legal Scenario: Insurance & State Aid, Advisory Board And Local Regulations
Part three of three-part series.
See previous stories:
Colorado's New Psychedelics Regulations: Co-Author Of The Bill Replies To Concerns
Psychedelics And Treatment-Resistant Depression: COMPASS Pathways Replies To Comments
(Part four of a four-part series)
See previous stories:
Psychedelic Therapy Boosted By 3D Movement Data? This Company Is Aiming To Patent The Combination
Canadian magic mushrooms and truffles producer Red Light Holland Corp.
Free Ketamine Therapy? Laid Off Tech Workers Can Request Month Of ‘Freedom’ Program
A considerable number of employees have been fired from their jobs at big tech firms.
Psychedelics Production Methods Expect Further IP Protection With 4 New Patents
Biotech company PsyBio Therapeutics Corp. (OTCQB: PSYBF) has filed four new U.S. Patent Cooperation Treaty (PCT) applications aiming to convert five provisional patent applications.
Psyched: Fed Guidelines And Research Production Quotas, Protests In Canada, Cal’s Decrim Project
Psychedelic Research & Fed Funding By The National Institute Of Mental Health
The National Institute of Mental Health (NIMH) named the types of psychedelics studies to which it would grant funds and further guidance for pre-clinical research and studies with young participants.
Europe To Have Expanded Access To Psychedelic-Assisted Therapy With New Norway Clinic
Psychedelics biotech Awakn Life Sciences Corp.
Psyched: Full-Dose & Microdosing LSD Studies, Research Scope For Fed Funding, Consumption Sites And More
LSD Research Ramps Up: Full-Dose & Microdosing For Alzheimer's Studies Led By Beckley Foundation Coming Soon
A Leading Ketamine Treatment Clinic For Alcoholism Is Expanding: Here’s The Latest
A psychedelics R&D biotech company, known for providing novel treatments for addictions, is opening a new ketamine clinic.
Psyched: Musk’s Empathy Tweets, Psychedelics In Congress, Oregon’s Opt-Outs, MAPS’ MDMA Trial And More
Elon Musk Joins Twitter Conversation Around Psychedelics: A Debate On Empathy